VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 187 filers reported holding VAXCYTE INC in Q1 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $95,995 | -7.4% | 1,883 | -9.3% | 0.06% | -4.9% |
Q2 2023 | $103,626 | +25.0% | 2,075 | -6.2% | 0.06% | +32.6% |
Q1 2023 | $82,868 | -43.6% | 2,211 | -27.8% | 0.05% | -40.3% |
Q4 2022 | $146,919 | +3.5% | 3,064 | -48.2% | 0.08% | +35.1% |
Q3 2022 | $142,000 | +10.9% | 5,910 | +0.8% | 0.06% | +21.3% |
Q2 2022 | $128,000 | – | 5,865 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 4,168,718 | $99,174,000 | 24.03% |
Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $44,903,000 | 11.24% |
Pivotal bioVenture Partners Investment Advisor LLC | 1,111,485 | $26,442,000 | 11.06% |
FRAZIER MANAGEMENT LLC | 2,309,554 | $54,944,000 | 4.23% |
Kynam Capital Management, LP | 211,483 | $5,031,000 | 2.69% |
GREAT POINT PARTNERS LLC | 500,000 | $11,895,000 | 2.64% |
Ghost Tree Capital, LLC | 250,000 | $5,948,000 | 2.13% |
RA Capital Management | 4,240,464 | $100,881,000 | 1.78% |
Opaleye Management Inc. | 315,800 | $7,513,000 | 1.59% |
Ikarian Capital, LLC | 295,111 | $7,021,000 | 1.05% |